Biotech firms Nona Biosciences and Alaya.bio collaborate to simplify CAR-T cell therapy development.
Biotech firms Nona Biosciences and Alaya.bio have partnered to advance CAR-T cell therapy. Their collaboration leverages Nona's HCAb Harbour Mice platform and site-specific conjugation technology with Alaya.bio's polymeric in situ delivery platform. The goal is to simplify CAR-T cell therapy development, manufacturing, and administration, leading to more promising therapies for patients globally.
July 15, 2024
3 Articles